Target intelligence / Profile preview

Peptidyl-prolyl cis-trans isomerase A (PPIA)

Target
PPIA
Molecular classification
Enzyme, Peptidyl-prolyl cis-trans isomerase (PPIase), Cyclophilin family
01

Overview

Peptidyl-prolyl cis-trans isomerase A, also known as cyclophilin A or PPIA, is an enzyme encoded by the PPIA gene on chromosome 7. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in proteins, which facilitates proper protein folding and function. This enzyme plays key roles in regulating intracellular signaling pathways—including those involved in inflammation and apoptosis—and has been implicated in various diseases such as cancer, inflammatory disorders, and viral infections. Cyclophilin A binds to the immunosuppressive drug cyclosporin A; this interaction underlies its clinical relevance for immunosuppression by inhibiting T-cell activation through calcineurin pathway blockade. The protein belongs to the cyclophilin subfamily within the broader peptidyl-prolyl cis/trans isomerases family.

Other names
Cyclophilin ACypARotamase ACyclosporin A-binding proteinPPIase A
02

Mechanism of action

Immunosuppression via inhibition of T-cell activation when bound by cyclosporin A; the drug-target complex inhibits calcineurin signaling in lymphocytes

03

Biological functions

Protein folding and maturation (catalyzes cis-trans isomerization of proline residues)Regulation of intracellular signaling pathways (e.g., NF-kappa-B, MAP kinases)Apoptosis regulationInflammation modulation
04

Disease associations

Cancer (overexpressed in some cancers)Inflammatory diseases (e.g., atherosclerosis, arthritis)Viral infection (notably HIV and other viruses)
05

Interacting drugs

Cyclosporin A

Beyond the preview

Go deeper on Peptidyl-prolyl cis-trans isomerase A (PPIA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase A (PPIA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call